Mandate

Vinge Advises Carlsberg in Offer for Scottish & Newcastle

January 30, 2008

On January the 25th 2008 the Board of Directors of Carlsberg A/S and Heineken N.V, as one part, and, as the other part, Scottish & Newcastle plc, announced that they had agreed upon the terms in the offer for Scottish & Newcastle which in turn sprang from a jointly owned company by Carlsberg and Heineken. The offer is based upon Scottish & Newcastle estimated value of GBP 7,6 billion. Baltic Beverages Holding AB, the jointly owned company of Carlsberg and Scottish & Newcastle, has played an important role in the connection to the discussions that have preceded the agreement. Vinge acts as legal advisors to Carlsberg on Swedish queries.

Vinge’s team included Hans Bagger and Finn Madsen (Litigation), Erik Sjöman (Corporate Law and Public M&A), assisted by, among others, Christina Ramberg and Andreas Eriksson.       

Related

Vinge advises Morrow Bank AB (publ) in connection with the bank’s sale of parts of MedMera Bank and the sale of NPL portfolios

Vinge has advised Morrow Bank AB (publ) in connection with the divestment of parts of MedMera Bank’s operations to a leading global credit investment firm. The divestment is structured as a sale of shares and priced at a premium of approximately SEK 90 million above equity value as per the completion date. The transaction includes parts of MedMera’s banking operations such as IT infrastructure, organisation and management, whilst Morrow Bank retains MedMera’s performing loans, deposits, customers, the MedMera brand, the Coop partnership agreement as well as key personnel.
September 15, 2026

Vinge advises HealthCap in conjunction with its investment in AMRA Medical

HealthCap is investing in AMRA Medical AB, a company that analyses whole-body MRI images to classify and quantify an individual’s muscle and fat tissue throughout the body and places this in relation to human health and disease.
September 15, 2026

Vinge has advised EQT managed Scaleup Europe Fund on its investment in Tandem Health

Vinge has advised EQT managed Scaleup Europe Fund as lead investor in Tandem Health's USD 100 million Series B investment round, with participation from existing investors Kinnevik, Northzone, Amino Collective and Visionaries. Tandem Health is an AI healthcare company founded in 2023 and headquartered in Sweden. Tandem Health operates as an AI partner within the healthcare sector across Europe, providing AI medical assistant support to clinicians in connection with patient visits.
September 15, 2026